ACR point of care testing in diabetic kidney disease

Literature • Abbott Rapid Diagnostics International

About the CPD course

Diabetic kidney disease; and chronic kidney disease attributed to diabetes; occurs in 20-40% of patients with diabetes This feature article explores albumin-creatine ratio (ACR) point of care testing in people with diabetic kidney disease.

CPD Provider

Abbott Rapid Diagnostics International

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Abbott Rapid Diagnostics International

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.